Benefits of Sustained Virologic Response (SVR) Post Direct-acting Antiviral (DAA) Therapy

Publish date:
September 20, 2021
graphic image
AETC Source
South Central AETC, 
University of New Mexico Health Sciences Center, ECHO Institute / Project ECHO - NM Regional Partner

Training slides review the impact of SVR and the risk of diabetes in patients treated with DAAs for hepatitis C virus (HCV) compared to untreated patients, and discuss the impact of SVR on liver complications including hepatocellular carcinoma in patients with HCV.

Documents with preview

Browse more